However, in the 2008 version of the SNA, in-house R&D was reclassified as an investment in the company’s stock of knowledge, to be valued ‘on the basis of the total production costs including the costs of fixed assets used in production’.25 It became a final productive activity rather than just an intermediate cost towards that activity.
